Alexander Hardy is President and Chief Executive Officer of BioMarin Pharmaceutical Inc (BMRN). The company reported total compensation of $21,927,563 for fiscal year 2025.
| Salary | $1,130,769 |
|---|---|
| Bonus | $0 |
| Stock awards | $16,833,629 |
| Option awards | $1,909,310 |
| Non-equity incentive plan | $1,644,500 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $409,355 |
| Total | $21,927,563 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure BioMarin Pharmaceutical Inc filed April 21, 2026, accession 0001628280-26-026290.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $1,130,769 | $0 | $16,833,629 | $1,909,310 | $1,644,500 | $0 | $409,355 | $21,927,563 |
| FY2024 | President and Chief Executive Officer | $1,050,000 | $0 | $10,490,968 | $1,661,566 | $1,501,500 | $0 | $149,571 | $14,853,605 |
| FY2023 | President and Chief Executive Officer | $64,615 | $900,000 | $10,662,587 | $6,207,816 | $0 | $0 | $40,218 | $17,875,236 |
Totals as disclosed in each year's own compensation disclosure for BioMarin Pharmaceutical Inc.
| Peer-group chief executive median | $17,991,247 |
|---|---|
| Difference from that median | $3,936,317 |
| Percentile within the disclosed peer group | 71st |
| Peers with a disclosed figure | 14 |
Medians and percentiles are computed across the peer group BioMarin Pharmaceutical Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Alexander Hardy this page | President and Chief Executive Officer | $21,927,563 |
| Gregory Friberg | Executive Vice President and Chief Research & Development Officer | $7,174,583 |
| Brian Mueller | Executive Vice President and Chief Financial Officer | $6,831,812 |
| Cristin Hubbard | Executive Vice President and Chief Commercial Officer | $5,713,695 |
| C. Greg Guyer | Executive Vice President and Chief Technical Officer | $5,691,680 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full BioMarin Pharmaceutical Inc compensation brief.
Alexander Hardy's compensation sits inside BioMarin Pharmaceutical Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.